All resolutions passed at GM of Tissue Regenix

Writer, Stock Market Wire
Tuesday, August 8, 2017 - 13:51

Tissue Regenix Group has confirmed that all resolutions, including those in respect of the Offer and Acquisition announced by the Company on 20 July, were passed by shareholders at today's General Meeting.

Accordingly, the Company has applied to the London Stock Exchange for 400,000,000 New Ordinary Shares to be admitted to trading on AIM, which is expected to occur at 8.00 a.m. on 9 August.

At 1:51pm: (LON:TRX) Tissue Regenix Group PLC share price was 0p at 11.5p


Related content

Tissue Regenix secures additional coverage in the US for DermaPure

Tissue Regenix secured additional coverage with a US Group Purchasing Organization (GPO) for the use of DermaPure, a decellularized allograft dermis.

The company said the...

Thu, 04/04/2019 - 07:48


Tissue Regenix moves closer to profitability after revenue jumps

Regenerative medical devices company Tissue Regenix Group said it expected to move closer to its goal of generating 'sustainable profitability' in 2019 after it more...

Mon, 04/02/2019 - 14:17


Tissue Regenix signs European distribution agreement with Arthrex

Regenerative medical devices company Tissue Regenix Group said it had entered into an agreement allowing Arthrex to distribute its BioRinse bone portfolio throughout Europe, with...

Tue, 13/11/2018 - 09:19


Tissue Regenix confirms new CFO appointment

Manchester-based medical devices company Tissue Regenix Group confirmed that Gareth Jones had officially taken up the role of chief financial officer.

His appointment had been...

Mon, 29/10/2018 - 07:54


Tissue Regenix posts loss as costs offset higher revenue

Regenerative medical devices company Tissue Regenix Group posted a first-half loss, as higher revenue was offset by costs.

Pre-tax losses for the six months through...

Mon, 03/09/2018 - 09:21